Which of the following European pharmaceutical companies is a subsidiary of the Ranbaxy group?

Introduction / Context:
Indian pharmaceutical companies have expanded globally by acquiring or creating subsidiaries in Europe and other regions. This business awareness question asks you to identify which European pharmaceutical company listed in the options is a subsidiary of the Ranbaxy group, reflecting Ranbaxy's international expansion strategy.

Given Data / Assumptions:
- Ranbaxy is an Indian pharmaceutical company with international operations.- The question focuses on a European company that is a Ranbaxy subsidiary.- Options include Basics GmbH, Viatris GmbH, RPG Aventis and Bayer AG.- Only one of these is directly associated as a Ranbaxy owned company.

Concept / Approach:
Ranbaxy entered the German generics market by acquiring Basics GmbH, which then became its wholly owned subsidiary. This company operates in Germany and focuses on generic medicines. Bayer AG is a large, independent German life sciences and pharmaceutical company, not a subsidiary of Ranbaxy. Viatris is a global pharmaceutical company created by the merger of Mylan and Upjohn, and RPG Aventis does not correspond to a known Ranbaxy subsidiary. Knowing the history of Ranbaxy's acquisitions in Europe is key to this question.

Step-by-Step Solution:
Step 1: Recall that Ranbaxy strengthened its presence in Europe by acquiring a German generics company.Step 2: Identify that company as Basics GmbH, which became a 100 percent subsidiary of Ranbaxy.Step 3: Compare the remaining options. Bayer AG is a large independent multinational with its own history.Step 4: Recognise that Viatris GmbH and RPG Aventis are not documented as Ranbaxy subsidiaries.Step 5: Conclude that Basics GmbH is the only option that correctly matches a Ranbaxy owned European pharmaceutical company.

Verification / Alternative check:
To verify, think of press releases and business articles about Ranbaxy's acquisition strategy. Many reports highlight Ranbaxy buying Basics GmbH from Bayer to enter the German generics market. This acquisition is often cited as an example of an Indian generic manufacturer expanding into Europe. No similar association is commonly made between Ranbaxy and the other companies listed in the options, confirming that Basics GmbH is the correct choice.

Why Other Options Are Wrong:
Viatris GmbH: Viatris is its own multinational company formed by a merger and is not owned by Ranbaxy.RPG Aventis: This name does not correspond to a recognised Ranbaxy subsidiary; it appears to mix different corporate names.Bayer AG: A major German life sciences company, but it is an independent corporation and was actually the seller when Ranbaxy acquired Basics GmbH.

Common Pitfalls:
One common error is to choose Bayer AG simply due to its strong brand recognition in Europe. Another mistake is to assume that any company name with a European sound might belong to Ranbaxy. Instead, you should focus on specific acquisition stories you may have read about, particularly Ranbaxy buying Basics GmbH. Keeping a mental map of such high profile deals helps to answer many business awareness questions accurately.

Final Answer:
The European pharmaceutical company that is a subsidiary of Ranbaxy is Basics GmbH.